| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/20/2010 | US7700732 reconstitution of paste, concentrating, adding stabilizers, pasteurizing |
| 04/20/2010 | US7700731 Prokaryotic collagen-like proteins and uses thereof |
| 04/20/2010 | US7700730 Using viral capsid protein comprising RGD domain (arginine-glycine-aspartic acid) to treat and prevent cell proliferative, nervous system, autoimmune and allergic disorders |
| 04/20/2010 | US7700728 Use of chimeric receptors in a screening assay for identifying agonists and antagonists of cell receptors |
| 04/20/2010 | US7700727 Compositions and kits for detecting pathogen infection |
| 04/20/2010 | US7700726 chemokines; open reading frames; long terminal repeats; site directed mutagenesis; antibodies |
| 04/20/2010 | US7700725 HIV antisense proteins |
| 04/20/2010 | US7700724 Mixture comprising serum complement system protein (INSP163) use in preparation of vaccines and antibodies for treatment and prevention of infection, cell proliferative, skin, neurodegenerative, bone, inflammatory, respiratory system and autoimmune disorders |
| 04/20/2010 | US7700722 Polyoxyethylene glycol-modified tumor necrosis factor for higher concentrations, decreased viscosity, and improved stability; for treatment of inflammation |
| 04/20/2010 | US7700721 antiparallel peptide arrangement; self-assembling; bone repair |
| 04/20/2010 | US7700719 Mutant protofibril for active immunisation; synuclein genes, proteins; point mutations; Parkinson's disease; dementia; host cells |
| 04/20/2010 | US7700717 cyclic peptides conjugated to photoactive moieties for intraoperative diagnostic imaging, screening and real-time monitoring of photodynamic therapy efficiency |
| 04/20/2010 | US7700660 Method of treating chronic ulcers |
| 04/20/2010 | US7700615 comprises 4-methyl-3-nitro-benzoic acid as inhibitor and 1,3-bis(2-chloroethyl)-1-nitrosourea as chemotherapeutic agent; for treatment of breast cancer and melanomas |
| 04/20/2010 | US7700582 Pharmaceutical formulation |
| 04/20/2010 | US7700575 Methods of treating ocular conditions |
| 04/20/2010 | US7700572 SMAD7 inhibitors for the treatment of CNS diseases |
| 04/20/2010 | US7700571 Compositions and methods for liver growth and liver protection |
| 04/20/2010 | US7700570 Oligonucleotide mediated specific cytokine induction and prophylaxis and treatment of viral infection in a mammal |
| 04/20/2010 | US7700568 Protein kinase (PK); for increasing the susceptibility of a cell to DNA-damaging agents via hybridization of nucleic acids encoding DNA dependent protein kinases, preventing gene expression; genetic engineering |
| 04/20/2010 | US7700565 Peptide nucleic acid based guanidinium compounds |
| 04/20/2010 | US7700564 Analgesic effect by administering a drug delivery system of glutathione carrier covalently bonded to the exterior surface of an intercalation compound of polyethylene glycol and Vitamin E or a phosphholipid; crosses the blood-brain barrier; nervous system disorders; carrier-mediated transcytosis |
| 04/20/2010 | US7700563 Synthetic heparin-binding factor analogs |
| 04/20/2010 | US7700562 Use of —furin—“convertase” inhibitors in the treatment of fibrosis and scarring |
| 04/20/2010 | US7700561 Abuse-resistant amphetamine prodrugs |
| 04/20/2010 | US7700560 Compounds comprising two human GlxI inhibitors covalently linked via a diacid where each of the inhibitors may be the same or different and is an S-substituted glutathione or a prodrug thereof having a gamma-glutamyl amino group; length >50 Angstroms; antitumor, -carcinogenic, -proliferative agents |
| 04/20/2010 | US7700559 Gonadotropin releasing hormone analogues conjugates with steroid hormones |
| 04/20/2010 | US7700558 Methods for treating diabetes using fibroblast growth factor-like polypeptides |
| 04/20/2010 | US7700557 for treating diseases relating to angiogenesis; fusion protein possesses ribosome inactivating activity and ability to bind to cellular vascular endothelial growth factor (VEGF) receptors |
| 04/20/2010 | US7700556 Extracellular domain of CTLA4, with (a) methionine at position 27 and ending with aspartic acid at position 150 (b) an alanine at position 26 and ending with aspartic acid at position 150 ; binds CD80 and/or CD86 with greater avidity; lupus, lupus erythematosus, and lupus nephritis |
| 04/20/2010 | US7700555 Methods of treating diabetes |
| 04/20/2010 | US7700554 Compositions for modulating blood-brain barrier transport |
| 04/20/2010 | US7700553 Selective inhibition of NF-κB activation by peptides designed to disrupt nemo oligomerization |
| 04/20/2010 | US7700552 Macrocyclic inhibitors of hepatitis C virus |
| 04/20/2010 | US7700551 Hydrolysable polymeric FMOC-linker |
| 04/20/2010 | US7700550 Telavancin or its hydrochloride salt for infection, including MRSA infections; reduced tissue accumulation and/or nephrotoxicity |
| 04/20/2010 | US7700549 treating Type II diabetes, eating disorders, and insulin-resistance syndrome with exendin peptide analogs of given amino acid sequence |
| 04/20/2010 | US7700548 Using granulocyte colony stimulating factor as therapeutic agent through a slow release mechanism, in treatment of spontaneous abortion, preeclampsia, preterm labor |
| 04/20/2010 | US7700547 Preventing airway mucus production by administration of EGF-R antagonists |
| 04/20/2010 | US7700546 Therapeutic agent for cancer |
| 04/20/2010 | US7700545 Use of NF-κB inhibition in combination therapy for cancer |
| 04/20/2010 | US7700544 Compositions and methods for treating atherosclerosis |
| 04/20/2010 | US7700543 Use NF-κB inhibition in combination therapy for cancer |
| 04/20/2010 | US7700362 Method for screening therapeutic agents for disuse muscular atrophy using interaction between selected proteins and a polyubiquitin chain |
| 04/20/2010 | US7700361 Secretory or membrane protein expressed in skeletal muscles |
| 04/20/2010 | US7700358 Transformed microorganism comprising an isolated fragment of DNA derived from coffee and integrated into the genome or plasmid of the mannase; involved in the hydrolysis of polysaccharides |
| 04/20/2010 | US7700353 Compositions and methods for inducing apoptosis in tumor cells |
| 04/20/2010 | US7700351 Methods and compositions for tissue regeneration |
| 04/20/2010 | US7700341 Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon |
| 04/20/2010 | US7700334 immobilization with control over the orientation of the attachment; efficient, not requiring the previous purification of the protein to be attached, and can be activated by UV-light; photolithography |
| 04/20/2010 | US7700318 polypeptide comprising a TNF neutralizer domain, an IL-1 receptor antagonist domain, and a dimerization domain; rheumatoid arthritis or psoriasis |
| 04/20/2010 | US7700317 glycoprotein comprising the extracellular domain of a non-naturally occurring BAFF-R; BAFF (B-cell-activating factor of the TNF family); immunologic, autoimmune diseases, cancers, virus-associated diseases, renal, hypertensive diseases, conditions requiring immunosuppression, inflammation |
| 04/20/2010 | US7700316 CD109 nucleic acid molecules, polypeptides and methods of use |
| 04/20/2010 | US7700315 Comprises nucleotide sequences coding polypeptide with serine protease activity for use in identifying modulator and treaments for blood coagulation and cell proliferative disorders |
| 04/20/2010 | US7700314 Method for producing polyol-IFN-β conjugate |
| 04/20/2010 | US7700304 inhibiting formation of neurofibrillary tangles by reducing formation of a carboxyl-terminal truncated form of apolipoprotein E (apoE) in a neuron in the individual; animal models of Alzheimer's disease (AD); treating AD; drug screening |
| 04/20/2010 | US7700297 Artery- and vein-specific proteins and uses therefor |
| 04/20/2010 | US7700280 Methods for assessing cisplatin resistance, disease progression, and treatment efficacy in ovarian cancer |
| 04/20/2010 | US7700274 Compositions and methods in cancer associated with altered expression of KCNJ9 |
| 04/20/2010 | US7700272 Ligand gated chloride channel for use as screening tool in identifying/screening pesticidal and antiparasitic agents |
| 04/20/2010 | US7700132 Isolated material having an anti-organotrophic effect |
| 04/20/2010 | US7700122 Topical compositions comprising an opioid analgesic and an NMDA antagonist |
| 04/20/2010 | US7700120 Adjuvancy and immune potentiating properties of natural products of Onchocerca volvulus |
| 04/20/2010 | US7700119 85kDa neisserial antigen |
| 04/20/2010 | US7700113 Inhibiting breast cancer cell growth by administering an intracellular domain of NOTCH2 |
| 04/20/2010 | US7700112 FSH beta mutants that are glycosilated at residues N55 and T57 |
| 04/20/2010 | US7700109 Biomolecule transduction motif Mph-1-BTM and the use thereof |
| 04/20/2010 | US7700108 inducer of cytotoxic T cells; use of a tumor antigen protein PBF and a gene encoding the same cancer immunology; tumor marker |
| 04/20/2010 | US7700105 Methods of inducing IL-10 production |
| 04/20/2010 | US7700102 Stimulant immunology response; prevent infections |
| 04/20/2010 | US7700100 FcγRIIB fusion proteins and compositions thereof |
| 04/20/2010 | US7700095 Detection, isolation and uses of renalase (monoamine oxidase c) |
| 04/20/2010 | US7700092 Pneumovirus NS proteins antagonize the interferon IFN response |
| 04/20/2010 | US7700088 Interleukin-9 mutein peptides |
| 04/20/2010 | US7700087 Compounds and methods to inhibit or augment an inflammatory response |
| 04/20/2010 | US7700085 Administering an agent which inhibits binding of advanced glycation endproducts to any of their receptors; wound healing |
| 04/20/2010 | US7700083 Skin care composition for accelerated production of collagen proteins and method of fabricating same |
| 04/20/2010 | US7700073 Use of NF-κB inhibition in combination therapy for cancer |
| 04/20/2010 | US7699832 Medical device having a surface including a biologically active agent therein, and methods |
| 04/20/2010 | CA2563185C Sustained release formulations of a peptide or protein and a purified gallic acid ester |
| 04/20/2010 | CA2515366C Compositions and methods to modulate immune and inflammatory responses |
| 04/20/2010 | CA2435392C Desiccated avian sternal cartilage powder |
| 04/20/2010 | CA2433335C Particles for inhalation having sustained release properties |
| 04/20/2010 | CA2421058C Protein hydrolysates produced with the use of marine proteases |
| 04/20/2010 | CA2417207C Dental products comprising bone growth enhancing peptide |
| 04/20/2010 | CA2400172C Nanocapsule encapsulation system and method |
| 04/20/2010 | CA2388240C Phenoxy carboxylic acid compounds and compositions for delivering active agents |
| 04/20/2010 | CA2362331C Epoxide hydrolase complexes and methods therewith |
| 04/20/2010 | CA2359573C Conjugates of colony stimulating factors for targeting and imaging infection and inflammation |
| 04/20/2010 | CA2330549C Diacylglycerol o-acyltransferase |
| 04/20/2010 | CA2319680C Compounds and compositions for delivering active agents |
| 04/20/2010 | CA2306442C Human ribonuclease a with reduced ribonuclease inhibitor affinity |
| 04/20/2010 | CA2287541C Regulatory system for inducible expression of genes with lambdoid promoters |
| 04/20/2010 | CA2279331C Compounds and compositions for delivering active agents |
| 04/20/2010 | CA2229078C Pharmaceutical composition containing il-10 |
| 04/20/2010 | CA2223906C Replacement therapy for dental caries |
| 04/20/2010 | CA2219876C Stable variant hk2 polypeptide |
| 04/20/2010 | CA2212702C Mucosal vascular addressins and uses thereof |
| 04/20/2010 | CA2181433C Materials and methods for management of hyperacute rejection in human xenotransplantation |
| 04/20/2010 | CA2180872C Composition containing nucleic acids, preparation and uses |